WeSearch

Measles Is Becoming So Common That Treatments May Soon Be Needed

Emily Mullin· ·5 min read · 0 reactions · 0 comments · 6 views
#measles#becoming#common#treatments#soon
Measles Is Becoming So Common That Treatments May Soon Be Needed
TL;DR · WeSearch summary

It will likely be years, however, before these countermeasures are available, and it’s even more uncertain if those who refuse vaccines would take such treatments.Fueled by large outbreaks in South Carolina and Utah, the US had already surpassed last year’s 2,289 measles cases, and it’s only July. For comparison, there were just 285 cases in all of 2024.Because measles is so contagious, at least 95 percent of people in a community need to receive both doses of the measles vaccine to protect immunocompromised individuals and infants under 12 months old who are too young to be vaccinated. But measles vaccination rates have dipped well below that in many places across the country.Young children are the most susceptible to severe complications from measles.

Key facts
About this source

WIRED files mainly under tech. We currently carry 502 of its stories.

Original article
WIRED · Emily Mullin
Read full at WIRED →
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherWIRED
Canonical URLhttps://www.wired.com/story/measles-treatments-soon-needed/
Publication timeMon, 27 Jul 2026 09:30:00 +0000
Retrieval time2026-07-27T09:36:09.479Z
Last seen2026-07-27T09:36:09.479Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
Cluster3uef2ZVmZ_nH · 1 stories
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

Emily MullinScienceJul 27, 2026 5:30 AMMeasles Is Becoming So Common That Treatments May Soon Be NeededAs the US sees its highest number of measles cases in decades and vaccination rates fall, researchers are developing drugs to help those who contract the virus or who are particularly vulnerable.Photo-illustration: WIRED Staff; Getty ImagesCommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyUp until recently, measles vaccination has been so effective that there’s been little medical or financial incentive to develop treatments for the disease.But as measles cases hit a 35-year high and vaccination rates continue to decline in the US, a handful of biotech companies and academic groups have started working on measles treatments for those infected with the virus as…

Excerpt limited to ~120 words for fair-use compliance. The full article is at WIRED.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from WIRED